» Articles » PMID: 27976378

The Human Brain Endothelial Barrier: Transcytosis of AAV9, Transduction by AAV2: An Editorial Highlight for 'Trafficking of Adeno-associated Virus Vectors Across a Model of the Blood-brain Barrier; a Comparative Study of Transcytosis And...

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2016 Dec 16
PMID 27976378
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Read the highlighted article 'Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells' on page 216.

Citing Articles

Adeno-associated virus vector delivery to the brain: Technology advancements and clinical applications.

Ye D, Chukwu C, Yang Y, Hu Z, Chen H Adv Drug Deliv Rev. 2024; 211:115363.

PMID: 38906479 PMC: 11892011. DOI: 10.1016/j.addr.2024.115363.


Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2 Gangliosidosis.

Vyas M, Deschenes N, Osmon K, Chen Z, Ahmad I, Kot S Int J Mol Sci. 2023; 24(19).

PMID: 37834060 PMC: 10572999. DOI: 10.3390/ijms241914611.


A blood-brain barrier-penetrating AAV2 mutant created by a brain microvasculature endothelial cell-targeted AAV2 variant.

Kawabata H, Konno A, Matsuzaki Y, Hirai H Mol Ther Methods Clin Dev. 2023; 29:81-92.

PMID: 36970652 PMC: 10036519. DOI: 10.1016/j.omtm.2023.02.016.


A Multifaceted Approach to Optimizing AAV Delivery to the Brain for the Treatment of Neurodegenerative Diseases.

Fischell J, Fishman P Front Neurosci. 2021; 15:747726.

PMID: 34630029 PMC: 8497810. DOI: 10.3389/fnins.2021.747726.


EGFR-Binding Peptides: From Computational Design towards Tumor-Targeting of Adeno-Associated Virus Capsids.

Feiner R, Kemker I, Krutzke L, Allmendinger E, Mandell D, Sewald N Int J Mol Sci. 2020; 21(24).

PMID: 33333826 PMC: 7765298. DOI: 10.3390/ijms21249535.